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Introduction: Coronary artery disease (CAD) surveillance has led to the development of risk 
stratification tools that drive clinical mitigation efforts for CAD risk. As common risk assessment 
tools, including the Framingham Risk Score (FRS) or Pooled Cohort Risk Equations, have 
insufficient accuracy on an individual level to meet NASA’s stringent screening guidelines, NASA has 
required new approaches to address the risk of catastrophic cardiovascular (CV) medical events 
among astronauts. Coronary artery calcium (CAC) scanning has emerged as the current best tool to 
enhance CV risk assessment in asymptomatic individuals, with risk information incremental to FRS 
data.  
  
Methods: The Bellagio II Summit sought to identify current methods of risk stratification for CAD in 
high-performance operational environments, including military and spaceflight populations, to 
identify potential terrestrial applications of such tools. We reviewed NASA risk stratification tools 
and clinical mitigation strategies, comparing techniques with generalized and military terrestrial 
approaches and guidelines.  
  
Results: Current NASA screening and monitoring techniques have led to the development of the 
astronaut CV health and risk modification (ASTRO-CHARM) model, a risk assessment tool 
developed specific to the astronaut population for comprehensive assessment of atherosclerotic CV 
(ASCVD) disease. To develop ASTRO-CHARM, Khera et al. combined participant level data from 
three population-based cohorts: the Dallas Heart Study, Multiethnic Study of Atherosclerosis 
(MESA), and the Prospective Army Coronary Calcium (PACC) study. Cox proportional hazard 
models were created with traditional risk factors as the independent variables (age, sex, race, total 
cholesterol, HDL, systolic blood pressure, use of antihypertensive medications, smoking history, 
and glucose). Family history of myocardial infarction, C-reactive protein, and statin use were also 
tested to determine if they were independently associated with the outcome and improved model-
fit statistics.  This risk model has been internally and externally (from Framingham CAC cohort) 
validated. 
 
Discussion: The ASTRO-CHARM tool is the first integrated ASCVD risk calculator to incorporate 
risk factor and CAC data. While developed for specific application in the astronaut population, 
clinical assessment tools and associated mitigation techniques provide a comprehensive 
understanding of CV risk and subsequent clinical interventions. These tools can be implemented for 
terrestrial applications to augment current clinical practice in patients of similar age and sex. 
  
LEARNING OBJECTIVES: 
1   Understand the development of ASTRO-CHARM cardiac risk assessment. 
2   Understand the use of AC for assessing astronaut risk for a 6 month to 1 year mission to the ISS. 
3   Understand how this risk assessment tool can be translated to the terrestrial environment for 
clinical utilization. 
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MOC QUESTIONS: 
Question 1 
The use of ASTRO-CHARM to assess 10 year risk for predicting myocardial infarction, non-fatal 
stroke, and cardiovascular death includes coronary calcium scoring and is more accurate than the 
Framingham Risk Score for an astronaut population. (True/ False) 
Answer: True 
  
Question 2 
The use of ASTRO-CHARM for predicting a 1 year cardiovascular risk in a population similar to 
astronauts has been validated.  (True/ False) 
Answer:  True   
  
Question 3 
Which of the following health parameters are utilized in the ASTRO-CHARM risk model. 
a.      Age 
b.      Cholesterol 
c.      Smoking history 
d.      Hypertension 
e.      Family History 
f.       Inflammatory marker (CRP) level 
g.      Coronary Artery Calcium score 
h.      all of the above 
  
Answer:   all of the above   
 
